Picture of Aurora Cannabis logo

ACB — Aurora Cannabis News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapTurnaround

Canada's Aurora Cannabis Q3 revenue beats on higher sales in Germany and Poland

Overview

Canada medical cannabis firm's fiscal Q3 revenue rose, beating analyst expectations

Adjusted EBITDA for fiscal Q3 remained strong

Company to exit lower-margin consumer cannabis markets, focusing on medical cannabis

Outlook

Aurora expects fiscal 2026 global medical cannabis revenue between C$269 mln and C$281 mln

Company anticipates fiscal 2026 adjusted EBITDA to rise to C$52 mln-C$57 mln

Aurora plans to exit certain Canadian consumer cannabis markets in Q4 FY26

Result Drivers

MEDICAL CANNABIS GROWTH - Aurora's global medical cannabis net revenue increased by 12%, driven by higher sales in Germany and Poland

CONSUMER CANNABIS DECLINE - Consumer cannabis net revenue fell 48% as Aurora prioritized higher-margin medical cannabis products

PLANT PROPAGATION INCREASE - Plant propagation net revenue rose 27% due to organic growth and expanded product offerings

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueBeatC$94.19 mlnC$92.37 mln (6 Analysts)
Q3 Adjusted Net IncomeC$7.22 mln
Q3 Adjusted EBITDAC$18.48 mln
Q3 Adjusted Gross Margin62.00%
Q3 Adjusted Gross ProfitC$55.60 mln
Q3 Net Income from Cont Ops-C$1.70 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell" Wall Street's median 12-month price target for Aurora Cannabis Inc is C$8.50, about 53.2% above its February 3 closing price of C$5.55 The stock recently traded at 75 times the next 12-month earnings vs. a P/E of 30 three months ago Press Release: ID:nCNW8fzvFa For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Aurora Cannabis

See all news